NCT01338805View on ClinicalTrials.gov

Phase II BGG492 Capsule Extension for Partial Epilepsy

PHASE2CompletedINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

June 30, 2011

Primary Completion Date

July 31, 2012

Study Completion Date

July 31, 2012

Conditions
Partial Onset Seizures
Interventions
DRUG

BGG492

Trial Locations (16)

1096

Novartis Investigative Site, Budapest

6000

Novartis Investigative Site, Kecskemét

9700

Novartis Investigative Site, Szombathely

16321

Novartis Investigative Site, Bernau

32308

Novartis Investigative Site, Tallahassee

33617

Novartis Investigative Site, Bielefeld

53105

Novartis Investigative Site, Bonn

75230

Novartis Investigative Site, Dallas

77694

Novartis Investigative Site, Kehl-Kork

89081

Novartis Investigative Site, Ulm

97517

Novartis Investigative Site, Banská Bystrica

08619

Novartis Investigative Site, Hamilton

02-957

Novartis Investigative Site, Warsaw

041 90

Novartis Investigative Site, Košice

110 744

Novartis Investigative Site, Seoul

135-710

Novartis Investigative Site, Seoul

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY